ScoreWhy is West Pharmaceutical Services, Inc. ?
1
High Management Efficiency with a high ROE of 22.89%
2
Company has a low Debt to Equity ratio (avg) at times
3
Healthy long term growth as Operating profit has grown by an annual rate 12.66%
4
Flat results in Jun 25
- OPERATING CASH FLOW(Y) Lowest at USD 676.7 MM
5
With ROE of 18.49%, it has a fair valuation with a 6.12 Price to Book Value
- The stock is trading at a premium compared to its peers' average historical valuations
- Over the past year, while the stock has generated a return of -11.67%, its profits have fallen by -14%
6
Underperformed the market in the last 1 year
- Even though the market (S&P 500) has generated returns of 12.94% in the last 1 year, the stock has hugely underperformed and has generate negative returns of -11.67% returns
Real-Time Research ReportHow much should you hold?
- Overall Portfolio exposure to West Pharmaceutical Services, Inc. should be less than 10%
- Overall Portfolio exposure to Pharmaceuticals & Biotechnology should be less than 30%
(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Biotechnology)
When to exit? - We will constantly monitor the company and suggest at the appropriate time to exit from the stock
Is West Pharmaceutical Services, Inc. for you?
High Risk, Low Return
Absolute
Risk Adjusted
Volatility
West Pharmaceutical Services, Inc.
-12.24%
-0.20
56.14%
S&P 500
13.22%
0.64
20.20%
Quality
Management Risk
Growth
Capital StructureQuality key factors
Factor
Value
Sales Growth (5y)
8.71%
EBIT Growth (5y)
12.66%
EBIT to Interest (avg)
100.00
Debt to EBITDA (avg)
0
Net Debt to Equity (avg)
-0.07
Sales to Capital Employed (avg)
0.98
Tax Ratio
20.26%
Dividend Payout Ratio
12.27%
Pledged Shares
0
Institutional Holding
100.00%
ROCE (avg)
32.01%
ROE (avg)
22.89%
ValuationValuation Key Factors 
Factor
Value
P/E Ratio
33
Industry P/E
Price to Book Value
6.12
EV to EBIT
27.17
EV to EBITDA
21.43
EV to Capital Employed
6.48
EV to Sales
5.61
PEG Ratio
NA
Dividend Yield
0.37%
ROCE (Latest)
23.86%
ROE (Latest)
18.49%
TechnicalsTechnical key factors
Indicator
Weekly
Monthly
MACD
Bullish
Mildly Bullish
RSI
No Signal
No Signal
Bollinger Bands
Bullish
Bearish
Moving Averages
Bullish (Daily)
KST
Bullish
Bearish
Dow Theory
Mildly Bearish
Mildly Bullish
OBV
No Trend
No Trend
Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish Turned 
Financial Trend4What is working for the Company
DIVIDEND PER SHARE(HY)
Highest at USD 5.32
RAW MATERIAL COST(Y)
Fallen by -8.48% (YoY
NET SALES(Q)
Highest at USD 766.2 MM
-2What is not working for the Company
OPERATING CASH FLOW(Y)
Lowest at USD 676.7 MM
Here's what is working for West Pharmaceutical Services, Inc.
Dividend per share
Highest at USD 5.32 and Grown
In each year in the last five yearsMOJO Watch
Company is distributing higher dividend from profits generated
DPS (USD)
Net Sales
Highest at USD 766.2 MM
in the last five periodsMOJO Watch
Near term sales trend is positive
Net Sales (USD MM)
Raw Material Cost
Fallen by -8.48% (YoY)
MOJO Watch
The company's ability to pass on the cost of raw materials to customers has improved; this may lead to a rise in profit margin
Raw Material Cost as a percentage of Sales
Depreciation
Highest at USD 41.4 MM
in the last five periodsMOJO Watch
The expenditure on assets done by the company may have gone into operation
Depreciation (USD MM)
Here's what is not working for West Pharmaceutical Services, Inc.
Operating Cash Flow
Lowest at USD 676.7 MM
in the last three yearsMOJO Watch
The company's cash revenues from business operations are falling
Operating Cash Flows (USD MM)
InfinHub Market Technologies FZ-LLC, Building-2, Unit 112, Dubai Internet City, Dubai, United Arab Emirates
GET THE MARKETSMOJO APP
Company
Stocks
Portfolio
"Investment in securities markets are subject to market risk. Read all the related documents carefully before investing."
